<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="159585">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01681394</url>
  </required_header>
  <id_info>
    <org_study_id>PBMCS-CTNS-01</org_study_id>
    <nct_id>NCT01681394</nct_id>
  </id_info>
  <brief_title>Effect of a Polyphenol-rich Cocoa Extract on Peripheral Blood Mononuclear Cells Gene Expression</brief_title>
  <official_title>Effect of the Administration of a Polyphenol-rich Cocoa Extract on Peripheral Blood Mononuclear Cells Gene Expression in Humans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Technological Centre of Nutrition and Health, Spain</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Technological Centre of Nutrition and Health, Spain</source>
  <oversight_info>
    <authority>Spain: Comité Ético de Investigación Clínica</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      It has been evidenced that chocolate and cocoa consumption increase vasodilation and reduce
      blood pressure. However, the mechanisms implicated in these effects have not been elucidated
      yet. The purpose of this study is to evaluate changes in gene expression induced by the
      administration of a polyphenol-rich cocoa extract in peripheral blood mononuclear cells
      (PBMC) in humans.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, randomized, controlled, double-blind and cross-over study. The
      intervention will consist in the administration of 250g of chocolate cream with or without
      the extract after 12 hours fasting. Blood samples will be taken at point 0, 2, 3 and 6 hours
      after the administration. At each time point, blood pressure and endothelial function (with
      a non-invasive method) will be measured.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2012</start_date>
  <completion_date type="Actual">February 2013</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Basic Science</study_design>
  <primary_outcome>
    <measure>Gene expression changes in PBMCs (using a microarray)</measure>
    <time_frame>0-6 hours</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>0-2-3-6 hours</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endothelial function (assessed by ischemic reactive hyperemia)</measure>
    <time_frame>0-2-3-6 hours</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma levels of procyanidins metabolites</measure>
    <time_frame>0-6 hours</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">25</enrollment>
  <condition>Cardiovascular Function</condition>
  <condition>Gene Expression</condition>
  <arm_group>
    <arm_group_label>Product 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>250 g of chocolate cream supplemented with 2.3 g of polyphenol-rich cocoa extract (containing 1050 mg of total polyphenols)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control product</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>250 g  of chocolate cream</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Polyphenol-rich cocoa extract</intervention_name>
    <description>250 g of chocolate cream supplemented with 2.3 g of polyphenol-rich cocoa extract (containing 1050 mg of total polyphenols)</description>
    <arm_group_label>Product 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Chocolate cream</intervention_name>
    <arm_group_label>Control product</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        1.Healthy males between the ages of 20 and 39 who do not meet any of the exclusion
        criteria.

        Exclusion Criteria:

          1. Body mass index (BMI) lower than 18 or greater than 27 Kg/m2

          2. Smokers

          3. Regular medication

          4. Consumption of medication during the last week

          5. Following a weight-loss diet

          6. Vegetarians

          7. Abnormal glucose levels

          8. Diabetes

          9. Cardiovascular disease

         10. Gastrointestinal disease

         11. Anemia

         12. Allergy
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rosa Solà, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Rovira i Virgili</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Technological Center of Nutrition and Health (CTNS)</name>
      <address>
        <city>Reus</city>
        <state>Tarragona</state>
        <zip>43204</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 2, 2013</lastchanged_date>
  <firstreceived_date>September 5, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
